Rashtriya Newsflash

Press Release

Treg Cell-Based Therapies Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Rapa Therapeutics, Orca Bio, Caladrius Biosciences, Sangamo Therapeutics, Quell Thera

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Treg Cell-Based Therapies pipeline constitutes key 51+ companies continuously working towards developing 55+ Treg Cell-Based Therapies treatment therapies, analysis of

Read Full Article

Synovial Sarcoma Market to Experience Notable Growth in Forecast Span by 2034, DelveInsight Predicts | Advenchen Lab, Ipsen, Daiichi Sankyo, OncoTherapy Science, Foghorn Therapeutics, BioAtla

The Key Synovial Sarcoma Companies in the market include – Advenchen Laboratories, Ipsen, Daiichi Sankyo, OncoTherapy Science, Foghorn Therapeutics, BioAtla, Inc., Takara Bio, C4 Therapeutics, Adaptimmune, Epizyme, Inc., and others.

Read Full Article

Sarcopenia Market Insights Highlight Expanding Outlook Till 2034, DelveInsight Evaluates | TNF Pharma, Lipocine, Biophytis, ImmunoForge, Rejuvenate Biomed, Keros Therapeutics, BPGbio, Oncocross

The Key Sarcopenia Companies in the market inlcude- TNF Pharmaceuticals, Lipocine, Biophytis, ImmunoForge, Rejuvenate Biomed, Keros Therapeutics, BPGbio, Oncocross, Mirscience Therapeutics, Turn Biotechnologies, NMD PHARMA, ImmunoForge, Dong Wha PHARM, and

Read Full Article

Night Vision Disturbances Market Positioned for Accelerated Development Through 2034, DelveInsight Finds | Ocuphire Pharma, Viatris

The Key Night Vision Disturbances Companies in the market include – Ocuphire Pharma/Viatris, and others.   DelveInsight’s “Night Vision Disturbances Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth

Read Full Article

Psoriasis Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | Sun Pharma, Bristol-Myers Squibb, UCB Biopharma, Affibody AB, Ventyx Biosciences, Aclaris Therapeutics, AbbVie

The Key Psoriasis Companies in the market inlcude – UCB Pharma, Novartis, Sun Pharmaceutical/ Almirall, Bausch Health, Boehringer Ingelheim, LEO

Read Full Article

Gout Pipeline Drugs Report 2025: MOA, Emerging Therapies, Clinical Trials, Treatment | DelveInsight

DelveInsight’s “Gout Pipeline Insight 2025” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in the Gout pipeline

Read Full Article

Beta Thalassemia Pipeline Drugs Report 2025: MOA, Emerging Therapies, Clinical Trials, Treatment | DelveInsight

DelveInsight’s “Beta Thalassemia Pipeline Insight 2025” report provides comprehensive insights about 22+ companies and 22+ pipeline drugs in the Beta

Read Full Article

Hereditary Transthyretin Amyloidosis Pipeline Drugs Report 2025: MOA, Emerging Therapies, Clinical Trials, Treatment | DelveInsight

DelveInsight’s “Hereditary Transthyretin Amyloidosis Pipeline Insight 2025” report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in the

Read Full Article

Hypercholesterolemia Pipeline Drugs Report 2025: MOA, Emerging Therapies, Clinical Trials, Treatment | DelveInsight

DelveInsight’s, “Hypercholesterolemia Pipeline Insight, 2025” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in Hypercholesterolemia pipeline landscape.

Read Full Article

Influenza Pipeline Drugs Report 2025: MOA, Emerging Therapies, Clinical Trials, Treatment | DelveInsight

DelveInsight’s “Influenza Pipeline Insight 2025” report provides comprehensive insights about 120+ companies and 120+ pipeline drugs in the Influenza pipeline

Read Full Article